CyDex Pharmaceuticals' Other Investors

CyDex Pharmaceuticals raised a round of funding on , . Investors include Kansas Technology Enterprise Corporation.

CyDex Pharmaceuticals develops drugs specifically designed to address limitations of current therapies for conditions such as bipolar disorder, schizophrenia, fungus, and canine motion sickness.…

Articles about CyDex Pharmaceuticals' Other Investors: